| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/30/2014 | US20140031298 Compositions and Methods for Localized Therapy of the Eye |
| 01/30/2014 | US20140031289 Poly(organophosphazene) containing degradation controllable ionic group, preparation method thereof and use thereof |
| 01/30/2014 | US20140031287 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) compound or a melanocortin-4 receptor (mic4) agonist peptide |
| 01/30/2014 | US20140031285 Photodegradable groups for tunable polymeric materials |
| 01/30/2014 | US20140031281 Polymer-based sustained release device |
| 01/30/2014 | US20140030360 Chlorine dioxide gel and manufacturing method thereof |
| 01/30/2014 | US20140030351 Therapeutic Polymeric Nanoparticle Compositions with High Glass Transition Temperature or High Molecular Weight Copolymers |
| 01/30/2014 | US20140030349 Granules in liquid dosage form |
| 01/30/2014 | US20140030345 Surface-Modified Heavy Metal Nanoparticles, Compositions And Uses Thereof |
| 01/30/2014 | US20140030344 Targeted synthetic nanocarriers with ph sensitive release of immunostimulatory agents |
| 01/30/2014 | US20140030334 Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes |
| 01/30/2014 | US20140030327 Tamper resistant dosage forms |
| 01/30/2014 | US20140030320 Biodegradable Polyphosphazenes Containing Pyrrolidone Side Groups |
| 01/30/2014 | US20140030316 Transdermal administration of fentanyl and analogs thereof |
| 01/30/2014 | US20140030315 Nanofiber scaffolds for biological structures |
| 01/30/2014 | US20140030282 Anti-cd79b antibodies and immunoconjugates |
| 01/30/2014 | US20140030281 Anti-cd22 antibodies and immunoconjugates |
| 01/30/2014 | US20140030280 Anti-cd79b antibodies and immunoconjugates |
| 01/30/2014 | US20140030279 Anti-cd22 antibodies and immunoconjugates |
| 01/30/2014 | US20140030278 Conjugates of tumor necrosis factor inhibitors to functionalized polymers |
| 01/30/2014 | US20140030265 Modified soluble fgf receptor fc fusions method |
| 01/30/2014 | US20140030214 Liquid formulation of g-csf |
| 01/30/2014 | US20140030186 Combined pharmaceutical preparation |
| 01/30/2014 | US20140030180 Manufacture of crystallite particles |
| 01/29/2014 | EP2689785A1 Method for generating dry vaccine powder formulation for intranasal delivery |
| 01/29/2014 | EP2689016A1 Immunogenic compositions in particulate form and methods for producing the same |
| 01/29/2014 | EP2688580A1 Vancomycin derivatives |
| 01/29/2014 | EP2688561A2 Transdermal compositions comprising an active agent layer and an active agent conversion layer |
| 01/29/2014 | EP2688559A2 Swallowable medication capsule |
| 01/29/2014 | EP2688558A2 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor |
| 01/29/2014 | EP2688556A2 Controlled release pharmaceutical dosage forms |
| 01/29/2014 | EP2688551A1 A composition and method |
| 01/29/2014 | EP2574343B1 Compound for skin application and use of same |
| 01/29/2014 | EP2515647B1 Pheromone compositions and methods of use |
| 01/29/2014 | EP2032129B1 Compositions of phenylephrine useful for treatment of respiratory illness |
| 01/29/2014 | EP1787993B1 Crystalline maltitol powder less prone to consolidation and method for production thereof |
| 01/29/2014 | EP1539122B1 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 01/29/2014 | CN103547676A Immunogenic compositions in particulate form and methods for producing the same |
| 01/29/2014 | CN103547596A Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms |
| 01/29/2014 | CN103547279A Lyophilized preparation of cytotoxic dipeptides |
| 01/29/2014 | CN103547273A Pre-filled syringe filling syringe having resin barrel with aqueous solution containing hyaluronic acid or salt thereof |
| 01/29/2014 | CN103547269A 抗癌剂组合物 Anticancer composition |
| 01/29/2014 | CN103547265A Rapidly dissolving oral tablet |
| 01/29/2014 | CN103547259A 控制释放药物剂型 Controlled release pharmaceutical dosage form |
| 01/29/2014 | CN103547258A Topical nitric oxide systems and methods of use thereof |
| 01/29/2014 | CN103547257A Use of a viscoelastic fluid for producing a medicinal product for surgically treating the eye |
| 01/29/2014 | CN103547252A Artificial oil bodies |
| 01/29/2014 | CN103539954A Hydrophobic modified choline phosphorylated chitosan self-assembled nano microparticle and preparation method thereof |
| 01/29/2014 | CN103539888A Organic and inorganic hybrid hydrogel as well as preparation method and application thereof |
| 01/29/2014 | CN103539866A Preparation method of controllable arginine coupled chitosan |
| 01/29/2014 | CN103539862A Long-acting recombinant follicle-stimulating hormone and application thereof |
| 01/29/2014 | CN103539861A Long-acting recombinant human follicle-stimulating hormone-Fc fusion protein (hFSH-Fc) |
| 01/29/2014 | CN103539860A Long-acting recombinant human follicle-stimulating hormone-Fc fusion protein (hFSH-Fc) |
| 01/29/2014 | CN103539096A Preparation method of hydroxyl zinc phosphate nano hollow spheres for drug carrier |
| 01/29/2014 | CN103536973A Polyvinyl alcohol magnetic particles as well as preparation method and application thereof |
| 01/29/2014 | CN103536937A Organic-inorganic complex lipid ultrasonography microcapsule and preparation method thereof |
| 01/29/2014 | CN103536935A Photosensitizer-modified core-shell structure magnetic nanocomposites and preparation method and application thereof |
| 01/29/2014 | CN103536934A Self-assembled nano-gene vector compound based on PAMAM (Poly Amido-Amine) and preparation method thereof |
| 01/29/2014 | CN103536931A Water-soluble beta-cyclodextrin polymer supramolecular inclusion complex of azithromycin and preparation method thereof |
| 01/29/2014 | CN103536930A Polylactic acid-polyethylene glycol-tumor penetrating peptide compound, preparation and application thereof |
| 01/29/2014 | CN103536929A Preparation method of HPMC (Hydroxyl Propyl Methyl Cellulose) liquor |
| 01/29/2014 | CN103536928A Medicinal hollow hard capsule mainly prepared from inorganic montmorillonoid and preparation method of medicinal hollow hard capsule |
| 01/29/2014 | CN103536927A Edaravone composition freeze-dried powder injection |
| 01/29/2014 | CN103536926A Preparation method of chitosan oligosaccharide nanoparticle |
| 01/29/2014 | CN103536923A Formulations for enhanced bioavailability of orally administered polar agents |
| 01/29/2014 | CN103536919A Tumor-targeted photodynamic medicine carrying nanoparticle as well as preparation method and application thereof |
| 01/29/2014 | CN103536906A Use of pegylated Type III Interferons for the treatment of hepatitis C |
| 01/29/2014 | CN103536900A Erythrogenin mimetic peptide-containing pharmaceutical composition |
| 01/29/2014 | CN103536898A Thymopentin (TP-5) drug composition |
| 01/29/2014 | CN103536896A Enalapril composition freeze-dried powder for injection |
| 01/29/2014 | CN103536895A Bionic nano carrier system for protein drug delivery and preparation method |
| 01/29/2014 | CN103536632A Self-microemulsifying brucea javanica oil oral granules and preparation method thereof |
| 01/29/2014 | CN103536631A Method for preparing enteric stone-like omphalia for treating cancers |
| 01/29/2014 | CN103536626A Magnetic pirarubicin nano-drug composite |
| 01/29/2014 | CN103536625A Nanometer cerium oxide composite and preparation method thereof as well as antioxidant |
| 01/29/2014 | CN103536624A Wettable three-ingredient white composition powder and preparation method thereof |
| 01/29/2014 | CN103536623A Potassium magnesium aspartate composition freeze-dried powder for injection |
| 01/29/2014 | CN103536620A Azlocillin sodium composition powder for injection |
| 01/29/2014 | CN103536619A Amoxicillin sodium and clavulanate potassium composition powder for injection |
| 01/29/2014 | CN103536618A Ganciclovir composition freeze-dried powder for injection |
| 01/29/2014 | CN103536617A Ceftazidine composition freeze-dried powder for injection |
| 01/29/2014 | CN103536612A Nifuratel-nysfungin vaginal expandable suppository and its preparation method and detection method |
| 01/29/2014 | CN103536611A Parasite pesticide |
| 01/29/2014 | CN103536609A Glycerophospholipids for the improvement of cognitive functions |
| 01/29/2014 | CN103536606A Wettable sulfamethoxydiazine powder and preparation method thereof |
| 01/29/2014 | CN103536604A Wettable sulfamethoxazole trimethoprim powder and preparation method thereof |
| 01/29/2014 | CN103536603A Wettable sulfamonomethoxine (sodium) powder and preparation method thereof |
| 01/29/2014 | CN103536596A Transdermal delivery of diclofenac, carbamazepine and benzydamine |
| 01/29/2014 | CN103536595A Acipimox composition tablet |
| 01/29/2014 | CN103536592A Metronidazole-furazolidone vaginal expandable suppository and its preparation method and detection method |
| 01/29/2014 | CN103536583A Proanthocyanidin sustained release nano-micro spheres, as well as preparation method and application thereof |
| 01/29/2014 | CN103536581A Nifedipine composition sustained-release capsule |
| 01/29/2014 | CN103536578A Cefixime capsule and preparation method thereof |
| 01/29/2014 | CN103536577A Tenofovir dipivoxil fumarate capsule and preparation method thereof |
| 01/29/2014 | CN103536576A Aliskiren composition capsule |
| 01/29/2014 | CN103536575A 乙酰半胱氨酸组合物胶囊 Acetylcysteine composition Capsules |
| 01/29/2014 | CN103536574A Coenzyme Q10 soft capsule and preparation method thereof |
| 01/29/2014 | CN103536571A Nizatidine composition tablet |
| 01/29/2014 | CN103536570A Cimetidine composition lyophilized oral-disintegration tablets |
| 01/29/2014 | CN103536566A Ramosetron hydrochloride injection and preparation method thereof |